*Endoscopy Humans Incidence Incidental Findings Male *Prostatectomy/methods Prostatic Hyperplasia Prostatic Neoplasms/diagnosis/*epidemiology

Humans Incidence Male Pain Postoperative/*epidemiology Pelvic Pain/*epidemiology Prostatic Hyperplasia Transurethral Resection of Prostate/*adverse effects Dysuria Pain Prostate Prostatic hyperplasia Transurethral resection of prostate Urological surgical procedures

Enucleation vaporization benign prostatic hyperplasia systematic review meta-analysis

Comparative Effectiveness Research Cost-Benefit Analysis Humans Male Operative Time *Postoperative Complications/etiology/therapy *Prostatectomy Prostatic Hyperplasia Recovery of Function *Robotic Surgical Procedures *Patient outcome assessment *Postoperative complications *Prostatectomy *Prostatic hyperplasia *Robotic surgical procedures

Acetanilides Adrenergic beta-3 Receptor Agonists Aged Humans Lower Urinary Tract Symptoms Male Prostatic Hyperplasia/complications/*drug therapy Randomized Controlled Trials as Topic Thiazoles Treatment Outcome Urinary Bladder Overactive/complications/*drug therapy Urological Agents Lower urinary tract symptoms Mirabegron Overactive Prostatic hyperplasia Urinary bladder

minimally invasive surgical procedures natural orifice endoscopic surgery prostate ablation devices robotic surgical procedures urology devices currently have a consulting agreement with PROCEPT BioRobotics.

Constriction Pathologic Humans Incidence Male Postoperative Complications/*epidemiology Prostatic Hyperplasia *Transurethral Resection of Prostate Urinary Bladder Neck Obstruction/*epidemiology Benign prostatic hyperplasia Laser therapy Postoperative complications Prostatectomy Transurethral Transurethral resection of prostate Urinary bladder neck obstruction

Ejaculation/physiology Humans Lower Urinary Tract Symptoms/etiology/physiopathology/therapy Male Minimally Invasive Surgical Procedures Prostatic Hyperplasia/complications/physiopathology/surgery/*therapy Randomized Controlled Trials as Topic Sexual Dysfunction Physiological/etiology Aquablation Benign prostatic hyperplasia Ejaculatory dysfunction Prostate artery embolization Prostatic urethral lift Water vapor thermal therapy

Thulium laser vaporesection of prostate bipolar transurethral resection of prostate benign prostate hyperplasia meta-analysis

Follow-Up Studies Humans Length of Stay Male Operative Time Postoperative Complications/etiology Prostatic Hyperplasia/complications Prostatism/etiology *Prostheses and Implants Quality of Life Severity of Illness Index Time Factors

Humans *Urinary Bladder Neoplasms/surgery/pathology Urologic Surgical Procedures Cystectomy *Laser Therapy *Lasers Solid-State/therapeutic use Turbt bladder tumor laser resection recurrence

Humans Mitomycin/therapeutic use Antibiotics Antineoplastic BCG Vaccine/therapeutic use *Non-Muscle Invasive Bladder Neoplasms Neoplasm Recurrence Local/drug therapy *Urinary Bladder Neoplasms/pathology Administration Intravesical Neoplasm Invasiveness Bladder cancer Device-assisted Emda Intravesical drug administration Nmibc

Cisplatin/adverse effects Humans *Immunotherapy/adverse effects/methods *Muscles/pathology *Neoadjuvant Therapy/adverse effects Neoplasm Staging *Urinary Bladder Neoplasms/drug therapy/pathology/therapy chemoimmunotherapy immunotherapy meta-analysis muscle-invasive bladder cancer (MIBC) neoadjuvant commercial or financial relationships that could be construed as a potential conflict of interest.

阿司匹林 膀胱癌 meta分析 发病风险

*Carcinoma Transitional Cell/pathology Female Humans Male Neoplasm Invasiveness Nephroureterectomy Sweden *Urinary Bladder Neoplasms/pathology Swedish national guidelines Urothelial carcinoma non-muscle invasive bladder cancer upper tract urothelial carcinoma

膀胱癌 腹腔镜膀胱根治性切除术 机器人辅助膀胱根治性切除术 体腔内尿流改道 体腔外尿流改道 原位新膀胱术

Follow-Up Studies Humans Medical Oncology Practice Guidelines as Topic *Urinary Bladder Neoplasms/diagnosis/therapy

Adjuvants Immunologic/*administration & dosage Administration Intravesical BCG Vaccine/*administration & dosage Humans *Lymphocytes Tumor-Infiltrating Treatment Outcome Urinary Bladder Neoplasms/*drug therapy/immunology/*pathology

Aged *Brachytherapy Combined Modality Therapy Disease-Free Survival Female Humans Male Middle Aged Neoplasm Recurrence Local *Urinary Bladder Neoplasms/mortality/pathology/radiotherapy external beam radiotherapy interstitial brachytherapy muscle-invasive bladder cancer organ preservation

Administration Intravesical Antibiotics Antineoplastic/*administration & dosage Antimetabolites Antineoplastic/*administration & dosage Deoxycytidine/administration & dosage/*analogs & derivatives Humans Mitomycin/*administration & dosage Neoplasm Invasiveness Randomized Controlled Trials as Topic Urinary Bladder Neoplasms/*drug therapy/pathology Gemcitabine Bladder cancer Meta-analysis Mitomycin Systematic evaluation